Entering text into the input field will update the search result below

Supernus Pharmaceuticals EPS of $0.08

Aug. 11, 2014 5:07 PM ETSupernus Pharmaceuticals, Inc. (SUPN) StockBy: Mohit Manghnani, SA News Editor
  • Supernus Pharmaceuticals (NASDAQ:SUPN): Q2 EPS of $0.08 may not be comparable to consensus of -$0.28.
  • Revenue of $29.68M beats by $9.83M.
  • Press Release

Recommended For You

More Trending News

About SUPN Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
SUPN--
Supernus Pharmaceuticals, Inc.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.